Doneene K. Damon
Considered “incredibly smart” and an “outstanding lawyer” (Chambers USA, 2025), Doneene Damon is chair of the firm’s Corporate Trust and Agency Services Group.
“When Doneene speaks, everyone listens” (Chambers USA, 2025). She focuses her practice on formation and operational issues relating to Delaware statutory trusts and Delaware and New York common law trusts in all types of commercial and business transactions, representing issuers, underwriters, investors, and trustees. Doneene advises clients on the use of common law trusts, statutory trusts, owner trusts, master trusts, series trusts, and titling trusts in connection with capital markets transactions.
”Experienced, careful, smart and very personable” (Chambers USA), Doneene was recently name among the Forbes Best-in-State Lawyers for Delaware, 2025. She is also named among the Philadelphia Business Journal’s Diversity Leaders in Business, the News Journal’s Most Influential Delawareans, Savoy Magazine’s Most Influential Black Lawyers, and a Women, Influence & Power in Law Managing Partner of the Year.
Her practice includes representing banks and trust companies in connection with their trust and agency services under Delaware and New York law in various commercial transactions, including their roles as trustee, collateral agent, verification agent, custodian, master servicer, depository agent, securities intermediary, paying agent, registrar and transfer agent, and exchange agent.
She also served as primary Delaware counsel in a series of first-to-market structured finance transactions employing the use of blockchain distributed ledger technology.
Doneene’s varied corporate trust transactional practice includes
asset-backed securities, including auto loans and leases, credit cards, student loans, consumer loans, residential mortgages, home equity loans, equipment leases, litigation settlements, insurance policies, and intellectual property;
collateralized loan obligations;
cross-border leasing transactions;
mutual funds and exchange traded funds;
health care receivables;
liquidation trusts;
voting trusts;
independent director and independent manager;
private equity funds;
defeasance transactions;
capital securities and hybrid capital securities; and
royalty trusts